IL17Qb therapeutic vaccines (Kuros Biosciences)

IL17Qb治疗性疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIL17Qb therapeutic vaccines (Kuros Biosciences)
Drug Alias NameCYT-017-IL17Qb
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin-17 modulators
TargetsInterleukin-17
Therapy Area/IndicationsPsoriasisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosciences
Active IndicationsN/A
Inactive IndicationsPsoriasisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A